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SUMMARY 
Background: The injection of mixture of plain bupivacaine and triamcinolone acetonide into the sacroiliac joint 
(SIJ) to relieve chronic low back pain is uncommon in the West African sub-region. The objective of this study was 
to demonstrate the efficacy or otherwise of fluoroscopic-guided SI joint injection in the management of chronic axi-
al low back pain in Nigeria. 
Design: This was a prospective observational interventional study 
Setting: The study was carried out at a tertiary hospital in Nigeria 
Participants: Twenty-six patients with SI joint pain, based on IASP diagnostic criteria, who presented to our unit 
over 36 months from March 2012 to March 2015 and.  
Interventions: Fluoroscopic-guided injections of 5mls mixture of bupivacaine and triamcinolone acetonide into the 
sacro-iliac (SI) joints of 26 patients with SI joint pain out of 116 patients who were offered different interventions 
for chronic low back pain. The patients were followed up for year and pain intensity and functional status were as-
sessed at 3-, 6- and 12 months post-intervention. 
Main outcome measures: Pain relief and functional improvement were the main outcome measures. 
Results: The mean numeric rating score (NRS) and Oswestry Disability index (ODI) score in 14 (53.9%) patients at 
12 months post-interventions were significantly lower compared with baseline values; 3.19 ± 1.10 vs 8.54 ±1.14 
p=0.000 and 25.35 ± 5.40 vs 37.54 ±8.41, p=0.000 respectively.  
Conclusion: Fluoroscopic-guided steroid injection into the SI joint resulted into reduction in pain intensity and im-
proved physical function in the majority of patients with SI joint pain. 
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INTRODUCTION 
Sacro-iliac (SI) joint is an important source of chronic 
axial low back pain;1, 2 with frequency of its occurrence 
increasing with age.2 The joint derives its innervations 
mainly from the dorsal rami of sacral nerves. Pain origi-
nating from the SIJ can be intra-articular, extra-articular 
or unknown. Intra-articular causes include infection, 
arthritis, spondyloarthropathies and malignancies while 
enthesopathy, fractures, ligamentous injuries and myo-
fascial pain constitute the extra-articular causes of SI 
joint pain.3 Based on the proposed criteria by the Inter-
national Association for the Study of Pain (IASP), SIJ 
pain is defined as pain localized in the region of the SI 
joint, reproducible by stress and provocation tests of SI 
joint, and reliably relieved by elective infiltration of the 
joint with local anaesthetic.4  
Conservative treatment of SIJ pain with analgesics, as 
usually the case with other specific causes of chronic 
low back pain, are ineffective. Consequently, patients 
continue to experience severe pain, impaired function 
and associated psychiatric co-morbidities leading to 
decrease in quality of life. Interventional pain manage-
ment techniques for specific sub-diagnosis of causes of 
back pain based on evidence-based practice guidelines 
have been shown to improve the chances of successful 
treatment outcome.3  
 
Evidence-based treatments of SI joint pain such as SIJ 
blocks, radiofrequency denervation’s (traditional and 
cooled), and fusion of the joint, especially following 
failed conservative management, can ameliorate pain 
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of diverse aetiologic causes. Availability of such ser-
vices in health facilities in Sub-Sahara Africa was virtu-
ally non-existent until recently.5  
 
Thus, assessing the benefits of SIJ block in patients with 
SIJ pain would broaden the existing treatment options 
for chronic low back pain and open new frontiers for 
research in the management of chronic low back pain in 
the region. This prospective observational study was 
conducted over a 3-year period (March 2012–March 
2015) to determine the efficacy, safety and acceptability 
of image-guided sacroiliac joint injections in the man-
agement of chronic axial low back pain secondary to SIJ 
pain among patients with chronic low back pain that 
presented to our centre. 
 
METHODS 
After approval from the Ethical Review Committee of 
University of Ilorin Teaching Hospital, Ilorin 
(ERCPAN/2014/03/1285), this prospective observation-
al study was carried out in a tertiary health institution in 
Nigeria, from March 2012 to March 2015, on 26 con-
secutive patients who met the specific diagnostic criteria 
of SIJ pain.  
 
Patients enrolled into the study had low back pain that 
included the region of the sacral sulcus with or without 
hip or leg symptoms; axial pain of more than 3 months 
duration; numerical rating scale (NRS) score of 5 at 
presentation, positive response to at least three widely 
accepted provocative maneuvers typically used to diag-
nose SIJ pain, such as the Patrick’s test, Gaenslen’s test, 
side-lying iliac compression test, midline sacral thrust, 
and pressure application to the sacral sulcus while in the 
prone position; and failure of pain to respond to non-
steroidal anti-inflammatory medications. Pregnancy, 
systemic infection or localized infection at anticipated 
point of needle entry, patient’s refusal to participate in 
the study, patients with depression or communication 
barrier that impedes ability to fulfill study end points, 
patients with spinal pathology such as scoliosis or spon-
dylolisthesis at L5/S1, symptomatic moderate or severe 
foraminal or central canal stenosis constituted the exclu-
sion criteria in this study. Under fluoroscopy, 5mls mix-
ture of plain bupivacaine and triamcinolone acetonide 
was injected into sacro-iliac (SI) joints of all the partici-
pants.  
 
Description of the procedure 
In the procedure room, patient was connected to a multi-
parameter patient monitor to obtain baseline vital signs 
and periodic cardio-respiratory parameters and venous 
access was secured.  
 
With patient in the prone position, the C-arm fluoro-
scope was placed in antero-posterior (AP) position to 
visualize the L5-S1 disc space at L5-S1 interspace. The 
widest space at the most inferior aspect of SI joint was 
identified and the C-arm was angled in cephalad (200) 
direction until the lines of anterior and posterior aspects 
of the joint overlapped.  
 
The needle entry point was at the inferior edge (distal 
1cm) of the joint and mixture of 1.0 mL of triamcino-
lone acetonide (6mg/mL) and 3mL of 0.25% plain bu-
pivacaine and 1% of lidocaine hydrochloride was in-
jected intra-articularly into the SI joint under fluoro-
scopic guidance. Patients were subsequently sent for 
physiotherapy session, consisting of lumbar stabilization 
techniques and reconditioning. An additional therapeu-
tic injection was scheduled for each patient. The addi-
tional therapeutic injection was nullified if patients ad-
mitted to at least an 80% symptom relief 2 weeks after 
the initial injection. Patients were re-evaluated 2 weeks 
after the first or second therapeutic injection. Failure to 
achieve pain relief after two therapeutic injections ruled 
out another scheduled injection.  
 
Outcome measures 
At presentation and before fluoroscopic-guided SIJ 
block, a baseline numeric rating score (NRS) and 
Oswestry disability index (ODI) scores were assessed 
and recorded for each patient. At 3-, 6- and 12 months 
follow up visits, NRS and ODI were evaluated and the 
scores were compared with the baseline values. In this 
study, clinically relevant treatment success was deemed 
to have been achieved when patients reported a drop in 
the NRS score ≥2.5 or a reduction in the ODI score of 
10 or greater.6,7 The impression of the patients about the 
treatment was assessed using patients global impression 
of change (PGIC) according to the following grading: 
very much improved, much improved, minimally im-
proved and not improved.8  
 
Statistical analysis  
The data obtained were analyzed with the Statistical 
Package for the Social Sciences (SPSS) version 20.0 
(SPSS Inc., Chic., Ill.). Means and standard deviations 
were calculated for continuous variables that described 
outcomes in the treated patients at baseline, 3, 6, and 12 
months. Statistical significance: P < 0.05 using stu-
dent’s paired t-test. Results for proportions are reported 
as percentages, followed by confidence intervals calcu-
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RESULTS 
Of the total 116 patients assessed for chronic low back 
pain, transformational epidural steroid injections, medi-
al branch blocks or both were offered to 96 patients and 
only 26 met the diagnostic criteria for sacro-iliac joint 
pain, putting the incidence at 22.4% (26/116) in our 
centre. The male to female (M:F) ratio was 1.6:1, the 
age ranged from 42 to 78 years with a mean age of 
57.50±10.1. Civil servants, retirees, self-employed, 
traders, and farmers constituted 50% (13), 19.2% (5), 
15.4% (4), 11.5% (2) and 3.9% (1) respectively of the 
patients who received the intervention. The left SIJ was 
more affected than the right in more than 70% (19) of 
the patients; duration of low back pain was greater than 
6 months in 76.9% (20) of the patients and the pain was 
localized in the gluteal region in 69.2% (18) of the pa-
tients, Table 1.  
 
More than two-thirds of the patients, 22 (84.6%), were 
placed on oral paracetamol and non-steroidal anti-
inflammatory drugs (NSAIDs) without desirable pain 
control and functionality, Table 1. At presentation, the 
mean pain intensity and functional disability scores, 
assessed by NRS and ODI, were 8.54±1.14 and 
37.34±8.44 respectively, Table 1. 
 
Table 1 Patients baseline characteristics and sites of 
pain 
Variables  Mean (SD) Min-Max N (%) 
Duration of LBP (years) 2.62 (1.39) 1-3  
Mean pain intensity 
(NRS) 
8.54 (1.14) 6-10  
Disability    
Oswestry Disability Index 
% (SD) 
37.5 (8.4) 25-56  
Analgesic use    
PCM+NSAIDs   22 (84.6) 
PCM   2 ()7.7 
Opioids   2 (7.7) 
Pain site    
Right SIJ   7  (26.9) 
Left SIJ   19 (73.1) 
NRS, Numeric rating scale; LBP, low back pain; ODI, oswestry disa-
bility index; PCM, paracetamol 
 
The mean baseline values and mean 6 months values of 
NRS and ODI were 8.54 ± 1.14 and 37.5 ± 8.4 versus 
4.15 ± 1.1 and 27.4 ± 7.8 respectively. The mean 6 
months changes in NRS and ODI from the baseline val-
ues were 4.4 ± 1.2 and 10.1 ± 5.0, and this indicated 
significant reductions in the mean NRS pain intensity 
and mean ODI score at 6 months follow up after the 
interventions. Similarly, the mean baseline values and 
mean 12 months values of NRS and ODI were 8.54 ± 
1.14 and 37.5 ± 8.4 versus 3.19 ± 1.1 and 25.0 ± 5.4 
respectively.  
 
However, only the difference in the mean ODI score 
reached statistical significance when the parameters 
were compared at 3- and 12 months post-treatment; 4.4 
± 5.3 versus 25 ± 5.4, p=0.000.  
 
 
Figure 1 Sacroiliac joint injection (PA view), needle is 
positioned at the inferior margin of the joint 
 
Mean NRS pain intensity scores declined by 5.9±1.6, 
4.4±1.2 and 5.4±1.5 points from baseline in 20 (77%), 
16 (62%) and 14 (54%) of the patients respectively at 3-
, 6-, and 12 months after interventions. Similarly, func-
tional status of patients improved significantly with 
mean ODI scores changes of 13.2±7.0, 10.1±4.9 and 
12.2±6.1 at 3-, 6-, and 12 months post intervention re-
spectively. At the end of 12 month follow up, 22 
(84.6%) of the patients were very satisfied with the 
treatment and the PGIC in the same percentage of pa-
tients was much improved on the patients global im-
pression of change (PGIC) assessment scale. 
 
 
Figure 2 The medial edge of ilium and lateral edge of 
sacrum are outlined in pink and purple respectively 
 
DISCUSSION 
The findings demonstrated that fluoroscopic-guided 
sacroiliac joint injections with local anaesthetic and 
corticosteroid are effective and safe in the treatment of 
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Majority of the patients achieved statistically significant 
and clinically relevant pain control and improved func-
tion (mean NRS and ODI changes at 12 months from 
the baseline values were 5.4 and 12.2 respectively, 
p<0.05.  
 
Outcome measures are deemed clinically relevant when 
a study established an 18 to 19mm reduction in visual 
analog scale (VAS)-based pain score or a 10-point im-
provement in the ODI6 in the setting of chronic pain 
setting; whereas a 3.5 to 4.7 point reduction in pain 
should be achieved in the setting of acute pain.7 
Recommended management approach for SI joint pain 
are conservative treatments such as analgesics, cogni-
tive-behavioural therapy, exercise therapy rehabilitation, 
and when indicated, psychiatric assessment as well as 
interventional pain techniques.3  
 
Intra-articular SIJ injection and radiofrequency neurot-
omy of nerves that supply the joint are the appropriate 
pain techniques when conservative management failed 
or only produced short term pain relief. Cooled radio-
frequency treatment of the lateral branches of S1 to S3 
(S4) should precede pulsed RF procedures which target 
L5 dorsal ramus and lateral branches of S1 to S3.3,9 In 
accordance with the recommended treatment guidelines, 
this study explored the efficacy and safety of intra-
articular SI joint injections in 26 patients with diagnosed 
chronic low back pain secondary to SI joint pain.  
 
The results of this study are consistent with the out-
comes of similar controlled studies 10,11 that established 
the beneficial effects of intra- and extra- articular injec-
tions. Luukainen and co-workers10 observed significant 
reduction in pain intensity in patients who were treated 
with intra-articular local anaesthestic and corticosteroid 
compared with the local anaesthetic and saline group 
one month after intervention. This study and 
Luukainen’s work delivered the local anaesthetic and 
corticosteroid into the SIJ intra-articluarly with similar 
satisfactory pain relief in the enrolled patients.  
 
Unlike Luukainen’s work however, this study lacked a 
control group and the patients were followed up for up 
to a year. Similarly, Maugars and co-workers11 reported 
pain reduction of >70% in 5 of the 6 SI joints one month 
after intra-articular corticosteroid injection; whereas no 
benefit was observed in the placebo group (7 SI joints) 
injected with normal saline. The follow ups in the Mau-
gars and group’s study and the present study were of 
equal duration and the intervention produced compara-
ble pain control in nearly equal number of patients in 
the two studies at the end of 6-month pain evaluation, 
58% vs 54%.  
 
Though we delivered the medications intra-articularly, 
two double-blind studies have demonstrated the effec-
tiveness of peri-articular infiltrations to provide short-
term pain relief.12,13 Therefore, peri-articular infiltration 
of approach can be used in case of difficult intra-
articular injection due to severe sacroilitis or presence of 
extra-articular causes of SI join pain.10,14 As noted in the 
previous studies cited above, there was no observed or 
reported major complication (s) such as intravascular 
uptake of the medications after the intervention apart 
from discomfort at the point of needle entry.  
 
Sacroiliac joint injection is effective and safe in patients 
with chronic axial low back pain secondary to sacroiliac 
joint pathology; and this study has proven the clinical 
benefit of the procedure due to the prolonged duration 
of pain relief in 50% of the patients at the end of 12-
month post-intervention. The impressions of the patients 
about the offered treatment was evaluated using PGIC 
and the responses were similar to the results obtained in 
a previous case report15 that examined the clinical bene-
fits and hindrances of facet radiofrequency procedure 
for chronic low back pain carried.  
 
The observed good impression of responses in the pa-
tients can be used as a surrogate to measure the accepta-
bility of the intervention.  
 
CONCLUSION 
Overall, good pain control, improved physical function-
ing and reduction in analgesic consumptions were 
achieved in (14) 54% of the patients at the end of one 
year follow up.  The discomfort of frequent ingestions 
of analgesics was reduced and compliance with medica-
tions enhanced. Attempting to use analgesics such as 
NSAIDs to achieve pain control for the same duration 
as offered by SIJ block in this study may increase the 
tendency to develop NSAIDs toxicity, especially in the 
elderly patients on steroid or those with co-morbid med-
ical conditions like peptic ulcer disease. Fluoroscopic-
guided SI joint injection is an effective, safe and ac-
ceptable treatment modality in patients with low back 
pain emanating from sacroiliac joint after failed con-
servative management. 
 
The limitations of this study included small sample size, 
lack of control group and failure to do diagnostic intra-
articular sacroiliac joint block before the therapeutic 
injections with local anaesthetic and corticosteroid. 
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